Boehringer Ingelheim and Immunai announced a collaboration focused on T-cell targets for drug discovery.
1 report, 1 independent
Updated Jun 25
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Boehringer Ingelheim and Immunai announced a collaboration focused on T-cell targets for drug discovery.